Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Shares of Elevance Health Inc. ELV shed 2.61% to $411.04 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.49% to 5,599.30 ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health, Inc. (NYSE:ELV) received a lot of attention from a substantial price movement on the NYSE over the last few months, increasing to US$411 at one point, and dropping to the lows of ...

with 15 “Strong Buy“ ratings on the stock. On Feb. 19, Cantor Fitzgerald analyst Sarah James reaffirmed an “Overweight“ rating on Elevance Health with a $485 price target, citing its ...

Over half a decade, Elevance Health managed to grow its earnings ... as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share ...

Investors in Elevance Health Inc (Symbol ... represents an approximate 3% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there ...